Improved Neurodevelopment Following In Utero Sulfonylurea Exposure in a Patient With KCNJ11 Permanent Neonatal Diabetes: Future Implications for Targeted Treatment During Pregnancy

Diabetes Care. 2024 Dec 17:dc241862. doi: 10.2337/dc24-1862. Online ahead of print.

Authors

Pamela Bowman^{1

2}, Maggie H Shepherd^{1

2}, Sarah E Flanagan¹, James Tonks^{1

3}, Maria Salguero-Bermonth⁴, Lisa Letourneau-Freiberg⁴, Siri A W Greeley⁴, Andrew T Hattersley^{1

2}

Affiliations

¹ University of Exeter Medical School, Exeter, U.K.
² Royal Devon University Healthcare NHS Foundation Trust, Exeter, U.K.
³ Haven Clinical Psychology, Bude, U.K.
⁴ Kovler Diabetes Center, The University of Chicago, Chicago, IL.

PMID: 39688637
DOI: 10.2337/dc24-1862

No abstract available

Publication types

Letter

Grants and funding